Stellenangebot: Postdoc | InVivo Vascular Remodeling in Pulmonary Fibrosis and COPD bei Boehringer Ingelheim Pharma GmbH & Co. KG

Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry's top investors in research and development, the company focuses on developing innovative therapies that can improve and extend lives in areas of high unmet medical need. Independent since its foundation in 1885, Boehringer takes a long-term perspective, embedding sustainability along the entire value chain. Our approximately 54,500 employees serve over 130 markets to build a healthier and more sustainable tomorrow. Learn more at www.boehringer-ingelheim.com
The Position
At Boehringer Ingelheim, we are committed to transforming the lives of patients suffering from severe pulmonary diseases. We are seeking a highly motivated and talented Postdoctoral Scientist to join our Vascular Health Cluster within Innovation & Research (I&R).
This position focuses on understanding the role of the pulmonary vasculature in chronic lung diseases, particularly pulmonary fibrosis (PF) and chronic obstructive pulmonary disease (COPD). While epithelial injury has long been considered a key driver of disease progression, growing evidence highlights the pulmonary endothelium as a critical regulator of vascular remodeling, inflammation, tissue homeostasis, and fibrosis. Aberrant endothelial responses contribute to vascular dysfunction, increased permeability, altered angiogenesis, and pathological tissue remodeling.
As a postdoctoral researcher, you will drive the development of innovative in vivo models and advanced imaging approaches to investigate vascular remodeling and identify new opportunities for therapeutic intervention and drug triaging
Discover our Biberach site: xplorebiberach.com
Postdoc: This Position is limited for 2 years.
To make it easier to find our job advertisements, we use the usual designation "postdoc". Of course, this advertisement is not only addressed to applicants directly after completing their doctorate, but to all qualified candidates.
Tasks & responsibilities

• One of your key responsibilities will be to establish, characterize and validate novel in vivo models of pulmonary vascular pathologies, including aberrant angiogenesis, pathological vascular sprouting and endothelial-to-mesenchymal transition (EndoMT).
• You will investigate vascular remodeling in pulmonary fibrosis and COPD and define robust, disease-relevant endpoints for mechanistic and pharmacological studies.
• In regard to quantitative vascular assessment, you will develop readouts for aberrant angiogenesis, vascular thickening, pulmonary vascular volume and structural changes within the pulmonary vasculature.
• Moreover, you will apply and further develop high-resolution micro-computed tomography (µCT) of isolated lungs and image-based quantification pipelines for vascular analysis.
• In addition, you will identify and evaluate tissue-based and circulating biomarkers associated with pulmonary vascular pathology and translate preclinical findings into novel therapeutic concepts.
• Furthermore, you will collaborate with internal and external experts, present your findings at scientific meetings and contribute to mentoring students and junior scientists where appropriate.

Requirements

• PhD in Biology, Biomedical Sciences, Pharmacology, Veterinary Medicine, Imaging Sciences or a related discipline.
• FELASA-B certification or an equivalent qualification that enables independent work with laboratory animals, together with hands-on experience in animal models.
• Experience with µCT imaging and/or advanced image analysis methods; experience with computational imaging or independent programming will be an advantage.
• Solid knowledge of molecular and cellular biology techniques, including flow cytometry (FACS), Western blotting, ELISA, PCR/qPCR, and protein and RNA analysis.
• Knowledge of pulmonary diseases, particularly pulmonary fibrosis and/or COPD; expertise in vascular biology, endothelial cell biology, angiogenesis or fibrosis research will be an advantage.
• Excellent communication and collaboration skills, with fluency in written and spoken English; German language skills will be a strong advantage.

As part of our commitment to transparency and fairness, salary information will be shared during the recruitment process. We also offer a comprehensive benefits and wellbeing package.
Applications from persons with severe disabilities are warmly welcomed. In cases of equal qualifications, such applicants will be given preferential consideration in the selection process.
With us, you can develop your own path in a company with a culture that knows our differences are our strengths - and break new ground in the drive to make millions of lives better.

Here, your development is our priority. Supporting you to build a career as part of a workplace that is independent, authentic and bold, while tackling challenging work in a respectful and friendly environment where everyone is valued and welcomed.

Alongside, you have access to programs and groups that ensure your health and wellbeing are looked after - as we make major investments to drive global accessibility to healthcare. By being part of a team that is constantly innovating, you'll be helping to transform lives for generations.

Want to learn more? Visit https://www.boehringer-ingelheim.com

Ready to contact us?
If you have any questions about the job posting or process - please contact our HR Direct Team, Tel: +49 (0) 6132 77-3330 or via mail: hr.de@boehringer-ingelheim.com
Recruitment process:
Step 1: Online application - The job posting is presumably online until September 10th, 2026. We reserve the right to take the posting offline beforehand.
Step 2: Virtual meeting in mid September
Step 3: On-site interviews beginning of October
Please submit your application documents in English.
This position has not been approved for the referral program by the department posting the job opening.